Virtual Reality Experience for Stress Reduction in Cardiology Patients

NCT04984655 | Completed

• 1 other identifier: 21-000705
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of the research is to evaluate the feasibility and scalability of delivering a 30-minute novel virtual reality (VR) experience through the Oculus Quest 2 Virtual Reality headset with the aim of measuring changes in: 1) patient-reported stress levels on a survey, 2) blood pressure, 3)heart rate, 4) respiration rate 5) heart rate variability 6) and galvanic skin response in cardiology clinic and cardiac rehabilitation patients.

Conditions

Stress; Blood Pressure; Virtual Reality; Prevention

Outcome Measures

Primary Outcomes (1)

• change in patient-reported stress levels on a survey

  immediately before 30-minute virtual reality experience and immediately after 30-minute virtual reality experience

Secondary Outcomes (6)

• change in systolic blood pressure

  immediately before 30-minute virtual reality experience and immediately after 30-minute virtual reality experience

• change in diastolic blood pressure

  immediately before 30-minute virtual reality experience and immediately after 30-minute virtual reality experience

• change in heart rate

  immediately before 30-minute virtual reality experience, during the 30-minute virtual reality experience, immediately after 30-minute virtual reality experience

• change in heart rate variability

  immediately before 30-minute virtual reality experience, during the 30-minute virtual reality experience, immediately after 30-minute virtual reality experience

• change in respiration rate

  immediately before 30-minute virtual reality experience and immediately after 30-minute virtual reality experience

Study Arms (1)

30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset

OTHER

Device: 30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset

Interventions

30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset DEVICE

All participants will go through the same intervention described above

30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years of age or older
• Current patient in University of California, Los Angeles (UCLA) Cardiology clinics and/or cardiac rehab
• English speaking
• Able to give informed consent

You may not qualify if:

• history of seizure
• facial injury preventing safe placement of headset, significant visual or hearing impairment (as defined as not able to see/hear clearly even with corrective lenses/aids).
• Individuals with dangerous, unstable arrhythmias (VTACH/VFIB) and/or myocardial infarction (MI) in past 4 week, or individuals in acute decompensated heart failure
• respiratory issues, postural instability, and motion sickness

Sponsors & Collaborators

• University of California, Los Angeles: lead

Study Sites (1)

Clinical and Translational Research Center, 10833 Le Conte suite BE144 - CHS building

Los Angeles, California, 90095, United States

Location

Study Officials

• Tamara Horwich, MD, MS

  University of California, Los Angeles

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Health Sciences Clinical Professor

Model Details: Pilot Study (uncontrolled)

Study Record Dates

• First Submitted: June 14, 2021
• First Posted: July 30, 2021
• Study Start: December 13, 2021
• Primary Completion: December 1, 2022
• Study Completion: December 1, 2022
• Last Updated: January 11, 2023

Record last verified: 2023-01

Locations

US (1)